Evercore ISI Group Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $55

Benzinga Newsdesk www.benzinga.com Negative 95.1%

Neg 95.1% Neu 0% Pos 0%

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $62 to $55.